Prostate Cancer

Prostate Cancer: Bone Decay Linked to Popular Treatment CBS News Preliminary research from Australia now links a common prostate cancer treatment called androgen deprivation therapy (ADT) to changes in bone structure that could increase the risk for fractures. An estimated 600000 prostate cancer patients in the US ... See all stories on this topic » CBS News

Sisters commemorate mother's life with breast cancer fundraiser Washington Post In two rooms at the Arlington Arts Center, a handful of models struck glamorous, statue-like poses against each side of the walls, shimmering eyelash extensions reaching inches from their eyes while nearly 50 admirers pointed and stared at them as if ... See all stories on this topic »

FDA says no to Jazz Pharma fibromyalgia drug The Associated Press PALO ALTO, Calif. — Federal regulators want additional clinical studies of a fibromyalgia drug candidate from Jazz Pharmaceuticals and the failure to get a go-ahead sent company shares down 11 percent before the market opened Monday. ... See all stories on this topic »

Autism linked to jaundice in newborns msnbc.com Babies diagnosed with worrisome jaundice are treated with special phototherapy lights that help break down bilirubin, a substance produced by the liver. By JoNel Aleccia Health writer Newborn babies who develop jaundice, a common liver problem that ... See all stories on this topic » msnbc.com

First patient treated in embryonic stem cell trial msnbc.com By Maggie Fox, Health and Science Editor WASHINGTON — US doctors have begun treating the first patient to receive human embryonic stem cells, but details of the landmark clinical trial are being kept confidential, Geron Corp said on Monday. ... See all stories on this topic »

New Alzheimer's guidelines aim for early diagnosis Reuters By Kate Kelland LONDON (Reuters) - Experts on Alzheimer's disease are proposing new criteria for diagnosing the dementia which would pick it up at an earlier stage and should get more patients onto treatment or into trials of new drugs. ... See all stories on this topic »

Abbott Labs Pulls Obesity Drug Zacks.com Abbott Labs (ABT - Analyst Report) recently announced its intention to pull obesity drug Meridia from the US market. Abbott Labs' decision was based on a request made by the US Food and Drug Administration (FDA). The FDA's request was based on data ... See all stories on this topic »

Alexza Shares Sink as the FDA Denies Its Antipsychotic Drug DailyFinance Alexza Pharmaceuticals (ALXA) shares are tanking some 50% in early trading after the company announced today that the US Food and Drug Administration has not approved its AZ-004, an antipsychotic inhaled drug for treating agitation in schizophrenia or ... See all stories on this topic »

Roche Reports Positive Data For Avastin In Ovarian Cancer Wall Street Journal ZURICH (Dow Jones)--Roche Holding AG (ROG.VX) Monday said data from a phase III study showed that its cancer drug Avastin helps women who suffer from ovarian cancer. The data were presented at the European Society of Medical Oncology, or ESMO, ... See all stories on this topic »